ING1
Basic information
Region (hg38): 13:110712736-110723339
Links
Phenotypes
GenCC
Source:
- head and neck squamous cell carcinoma (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ING1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 33 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 2 | 2 |
Variants in ING1
This is a list of pathogenic ClinVar variants found in the ING1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-110715453-G-T | not specified | Uncertain significance (May 27, 2022) | ||
13-110715519-G-C | not specified | Uncertain significance (Jun 17, 2024) | ||
13-110715532-T-C | not specified | Likely benign (Apr 24, 2024) | ||
13-110715552-C-A | not specified | Uncertain significance (Aug 15, 2023) | ||
13-110715589-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
13-110715595-G-C | not specified | Uncertain significance (May 23, 2024) | ||
13-110715634-C-G | not specified | Uncertain significance (Jun 06, 2023) | ||
13-110715673-C-T | not specified | Uncertain significance (Mar 23, 2022) | ||
13-110715709-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
13-110715720-A-C | not specified | Uncertain significance (Oct 27, 2022) | ||
13-110715724-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
13-110715768-T-TC | Benign (Jul 17, 2018) | |||
13-110715786-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
13-110715801-T-C | not specified | Likely benign (Apr 05, 2023) | ||
13-110715801-T-G | not specified | Uncertain significance (Nov 02, 2021) | ||
13-110715807-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
13-110715819-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
13-110715837-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
13-110715852-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
13-110715855-G-A | not specified | Uncertain significance (Dec 06, 2023) | ||
13-110715870-G-T | not specified | Uncertain significance (Nov 27, 2023) | ||
13-110715882-G-C | not specified | Uncertain significance (Sep 16, 2021) | ||
13-110715891-G-C | not specified | Uncertain significance (May 05, 2023) | ||
13-110715912-T-C | not specified | Uncertain significance (Feb 01, 2023) | ||
13-110715953-G-T | not specified | Uncertain significance (Jun 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ING1 | protein_coding | protein_coding | ENST00000375774 | 2 | 8339 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00967 | 0.981 | 122169 | 0 | 1 | 122170 | 0.00000409 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.493 | 255 | 278 | 0.917 | 0.0000180 | 2690 |
Missense in Polyphen | 35 | 112.65 | 0.31071 | 1031 | ||
Synonymous | -0.133 | 130 | 128 | 1.01 | 0.00000936 | 872 |
Loss of Function | 2.26 | 6 | 15.7 | 0.383 | 8.04e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000914 | 0.00000914 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cooperates with p53/TP53 in the negative regulatory pathway of cell growth by modulating p53-dependent transcriptional activation. Implicated as a tumor suppressor gene. {ECO:0000269|PubMed:9440695}.;
- Disease
- DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. {ECO:0000269|PubMed:10866301}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Senescence and Autophagy in Cancer
(Consensus)
Recessive Scores
- pRec
- 0.174
Intolerance Scores
- loftool
- 0.343
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.56
Haploinsufficiency Scores
- pHI
- 0.789
- hipred
- Y
- hipred_score
- 0.701
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.904
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ing1
- Phenotype
- neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cell cycle;negative regulation of cell population proliferation;regulation of cell death;negative regulation of cell growth;positive regulation of transcription, DNA-templated
- Cellular component
- nucleus
- Molecular function
- protein binding;methylated histone binding;metal ion binding